Competitive endogenous RNA (ceRNA) regulation network of lncRNAs, miRNAs, and mRNAs in Wilms tumour

作者: Fucai Tang , Zechao Lu , Jiamin Wang , Zhibiao Li , Weijia Wu

DOI: 10.1186/S12920-019-0644-Y

关键词: Gene expressionCompeting endogenous RNAComputational biologyKEGGDNA microarrayBiologyRNALong non-coding RNATranscription factormicroRNAGenetics(clinical)Genetics

摘要: Background Competitive endogenous RNAs (ceRNAs) have revealed a new mechanism of interaction between RNAs. However, an understanding of the ceRNA regulatory network in Wilms tumour (WT) remains limited. Methods The expression profiles of mRNAs, miRNAs and lncRNAs in Wilms tumour samples and normal samples were obtained from the Therapeutically Applicable Research to Generate Effective Treatment (TARGET) database. The EdgeR package was employed to identify differentially expressed lncRNAs, miRNAs and mRNAs. Functional enrichment analyses via the ClusterProfile R package were performed, and the lncRNA–miRNA–mRNA interaction ceRNA network was established in Cytoscape. Subsequently, the correlation between the ceRNA network and overall survival was analysed. Results A total of 2037 lncRNAs, 154 miRNAs and 3609 mRNAs were identified as differentially expressed RNAs in Wilms tumour. Of those, 205 lncRNAs, 26 miRNAs and 143 mRNAs were included in the ceRNA regulatory network. The results of Gene Ontology (GO) analysis revealed that the differentially expressed genes (DEGs) were mainly enriched in terms related to response to mechanical stimuli, transcription factor complexes, and transcription factor activity (related to RNA polymerase II proximal promoter sequence-specific DNA binding). The results of the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis showed that the DEGs were mainly enriched in pathways related to the cell cycle. The survival analysis results showed that 16 out of the 205 lncRNAs, 1 out of 26 miRNAs and 5 out of 143 mRNAs were associated with overall survival in Wilms tumour patients (P < 0.05). Conclusions CeRNA networks play an important role in Wilms tumour. This finding might provide effective, novel insights for further understanding the mechanisms underlying Wilms tumour.

参考文章(34)
Kiejung Park, Ki-Bong Kim, miRTar Hunter: A Prediction System for Identifying Human microRNA Target Sites Molecules and Cells. ,vol. 35, pp. 195- 201 ,(2013) , 10.1007/S10059-013-2165-4
Jonathan C. Routh, Paul E. Grundy, James R. Anderson, Alan B. Retik, Kyle C. Kurek, B7-H1 as a Biomarker for Therapy Failure in Patients with Favorable Histology Wilms Tumor The Journal of Urology. ,vol. 189, pp. 1487- 1492 ,(2013) , 10.1016/J.JURO.2012.11.012
Xun Zhang, Kimberley Rice, Yingying Wang, Wendy Chen, Ying Zhong, Yuki Nakayama, Yunli Zhou, Anne Klibanski, Maternally Expressed Gene 3 (MEG3) Noncoding Ribonucleic Acid: Isoform Structure, Expression, and Functions Endocrinology. ,vol. 151, pp. 939- 947 ,(2010) , 10.1210/EN.2009-0657
Efrosini Tsouko, Jun Wang, Daniel E. Frigo, Eylem Aydoğdu, Cecilia Williams, miR-200a inhibits migration of triple-negative breast cancer cells through direct repression of the EPHA2 oncogene Carcinogenesis. ,vol. 36, pp. 1051- 1060 ,(2015) , 10.1093/CARCIN/BGV087
Nathan Wong, Xiaowei Wang, miRDB: an online resource for microRNA target prediction and functional annotations Nucleic Acids Research. ,vol. 43, pp. 146- 152 ,(2015) , 10.1093/NAR/GKU1104
Ashwini Jeggari, Debora S Marks, Erik Larsson, miRcode: A map of putative microRNA target sites in the long non-coding transcriptome Bioinformatics. ,vol. 28, pp. 2062- 2063 ,(2012) , 10.1093/BIOINFORMATICS/BTS344
Marcio Malogolowkin, Cecilia A. Cotton, Daniel M. Green, Norman E. Breslow, Elizabeth Perlman, James Miser, Michael L. Ritchey, Patrick R.M. Thomas, Paul E. Grundy, Giulio J. D'Angio, J. Bruce Beckwith, Robert C. Shamberger, Gerald M. Haase, Milton Donaldson, Robert Weetman, Max J. Coppes, Patricia Shearer, Peter Coccia, Morris Kletzel, Roger Macklis, Gail Tomlinson, Vicki Huff, Robert Newbury, Douglas Weeks, Treatment of Wilms tumor relapsing after initial treatment with vincristine, actinomycin D, and doxorubicin. A report from the National Wilms Tumor Study Group. Pediatric Blood & Cancer. ,vol. 50, pp. 236- 241 ,(2008) , 10.1002/PBC.21267
Eugene B. Cone, Stewart S. Dalton, Megan Van Noord, Elizabeth T. Tracy, Henry E. Rice, Jonathan C. Routh, Biomarkers for Wilms Tumor: A Systematic Review. The Journal of Urology. ,vol. 196, pp. 1530- 1535 ,(2016) , 10.1016/J.JURO.2016.05.100
Enda Xue, Mingsheng Zhang, Wei Shao, Andrographolide promotes vincristine-induced SK-NEP-1 tumor cell death via PI3K-AKT-p53 signaling pathway. Drug Design Development and Therapy. ,vol. 10, pp. 3143- 3152 ,(2016) , 10.2147/DDDT.S113838
Yanzi Zang, Yong Tai, Baoluo Wan, Xiaodong Jia, miR-200a-3p promotes the proliferation of human esophageal cancer cells by post-transcriptionally regulating cytoplasmic collapsin response mediator protein-1. International Journal of Molecular Medicine. ,vol. 38, pp. 1558- 1564 ,(2016) , 10.3892/IJMM.2016.2758